Cargando…
Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway
Tumors may develop a variety of immune evasion mechanisms during the progression of colorectal cancer (CRC). Here, we intended to explore the mechanism of histone methyltransferase SETDB1 in immune evasion in CRC. The expression of SETDB1, microRNA-22 (miR-22), BATF3, PD-L1, and FOSB in CRC tissues...
Autores principales: | Tian, Jiale, Wang, Weiwei, Zhu, Jichao, Zhuang, Yun, Qi, Chunrun, Cai, Zhengxin, Yan, Wenhui, Lu, Wenying, Shang, Anquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045983/ https://www.ncbi.nlm.nih.gov/pubmed/35497876 http://dx.doi.org/10.1155/2022/4012920 |
Ejemplares similares
-
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer
por: Wu, Lipei, et al.
Publicado: (2022) -
Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response
por: Zhao, Zhipeng, et al.
Publicado: (2022) -
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
por: Rodriguez-Paredes, M, et al.
Publicado: (2014) -
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
por: Kato, Masaki, et al.
Publicado: (2018)